Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Anal cancer
Results 1-25 of 33 for your search:
Start Over
Topical or Ablative Treatment in Preventing Anal Cancer in Patients with HIV and Anal High-Grade Squamous Intraepithelial Lesions
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Prevention
Age: 35 and over
Trial IDs: AMC-A01, NCI-2014-00636, NCT02135419
A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: BBI608-201, NCI-2014-01566, NCT01325441
A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: BrUOG 276, NCI-2014-00505, NCT01671488
Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer
Status: Active
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 201404101, NCI-2013-00650, NCT01790035
Phase I/II Study of PDR001 in Patients With Advanced Malignancies
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CPDR001X2101, NCI-2015-00577, 2014-003929-17, NCT02404441
Cisplatin and Fluorouracil Compared with Carboplatin and Paclitaxel in Treating Patients with Inoperable Locally Recurrent or Metastatic Anal Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: EA2133, NCI-2015-00771, 13/LO/1463, 2013-001949-13, 3847, CCR 3847, InterAACT CCR 3847, NCT02051868
Self or Partner-Assisted Digital Anal Exam in Screening Participants for Anal Cancer
Status: Active
Phase: Phase II
Type: Screening
Age: 27 to 80
Trial IDs: HSC-SPH-13-0671, NCI-2015-00248, NCT02384005
Nivolumab and Synthetic Long E6/E7 Peptides Vaccine HPV-01 in Treating Patients with Recurrent or Metastatic Incurable HPV-16-Positive Solid Tumors
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2014-1047, NCI-2015-01004, NCT02426892
Surgery in Treating Patients with Early Stage Anal Canal or Perianal Cancer and HIV Infection
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Not specified
Trial IDs: AMC-092, NCI-2014-02056, 092, NCT02437851
Stereotactic Radiosurgery in Treating Patients with Oligometastatic Disease
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 10-027, NCI-2014-01952, REN13120042, UPCI #10-027, NCT01345539
Stereotactic Radiosurgery in Treating Patients with Oligo-Recurrent Disease
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 10-028, NCI-2014-01953, REN13120040, UPCI# 10-028, NCT01345552
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 3475-158, NCI-2015-02278, 163196, 2015-002067-41, NCT02628067
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: AMC-078, NCI-2011-02511, CDR0000689900, NCT01249443
High-Dose-Rate Brachytherapy and Chemotherapy in Treating Patients with Locally Recurrent or Residual Rectal or Anal Cancer Undergoing Non-operative Management
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 14-104, NCI-2014-01649, NCT02199236
A Phase 1 Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Solid Tumors
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: D4190C00010, NCI-2014-02609, NCT02261220
Alisertib and Combination Chemotherapy in Treating Patients with Gastrointestinal Tumors
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: VICC GI1536, NCI-2014-02475, 9824, NCT02319018
Collecting and Storing Tissue Samples From Patients With HIV-Associated Malignancies
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Tissue collection/Repository
Age: 18 and over
Trial IDs: AMC-083, NCI-2012-00718, CDR0000729843, NCT01567722
Collection of Tissue Samples in Identifying Novel Therapeutic Targets in Patients with Solid Tumors Undergoing Surgery or Biopsy
Status: Active
Phase: No phase specified
Type: Natural history/Epidemiology, Tissue collection/Repository
Age: 16 and over
Trial IDs: 12-C-0175, NCI-2015-01248, 320831, P121006, NCT01658917
Radiation Therapy, Fluorouracil, and Mitomycin in Treating Patients with Stage I-IIIB Anal Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13-075, NCI-2013-01820, NCT01858025
Anal HPV Tests in Screening for Cell Changes in the Anus in Patients with HIV
Status: Active
Phase: No phase specified
Type: Natural history/Epidemiology, Screening
Age: 18 and over
Trial IDs: AMC-084, NCI-2013-01637, NCT01946139
Magnetic Resonance Imaging in Planning Radiation Therapy in Patients with Liver, Brain, Head and Neck, or Pelvic Cancer
Status: Active
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: UMCC 2012.113, NCI-2012-02750, HUM00068061, NCT02045381
Natural History Study of Cancer Susceptibility in Patients with Fanconi Anemia, Inherited Bone Marrow Failure Syndromes, and Family Members
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Age: Not specified
Trial IDs: 02-C-0052, NCI-2013-02026, CGB 7130, NCT00056121, NCT00027274
Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors
Status: Active
Phase: No phase specified
Type: Health services research, Supportive care
Age: 18 to 39
Trial IDs: 9161, NCI-2014-01325, NCT02192333
Massage Therapy in Reducing Oxaliplatin-Induced Peripheral Neuropathy in Patients with Gastrointestinal Malignancies
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: 2014-0250, NCI-2015-00386, NCT02221700
Aerobic Exercise in Improving Cardiopulmonary Fitness and Tumor Neoplastic Phenotype in Patients with Gastrointestinal Cancer Undergoing Radiation Therapy and Surgery
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: Pro00055718, NCI-2015-02146, NCT02235441
Start Over